Advances in research on the species barrier in human and animal prion diseases

被引：0
|
作者：
Salwa, A
Iwanicki, A
机构：
[1] Zaklad Higieny Weterynaryjnej, PL-80316 Gdansk, Poland
[2] Uniwersytetu Gdanskiego, Katedra Biol Mol Wydzialu Biol Geog & Oceanol, PL-80822 Gdansk, Poland
来源：
MEDYCYNA WETERYNARYJNA-VETERINARY MEDICINE-SCIENCE AND PRACTICE | 2004年 / 60卷 / 01期
关键词：
prion diseases; PrPC; PrPSC;
D O I：
暂无
中图分类号：
S85 [动物医学（兽医学）];
学科分类号：
0906 ;
摘要：
Prion diseases are progressive and fatal neurodegenerative disorders in humans and animals and involve conformational conversion of cellular prion proteins (PrPC) into the pathological isoform (PrPSC). The article presents experiments in transgenic animals, tissue culture cells, sequential analysis and NMR of PrPC measurements carried out in order to identify the region in the PrPC important for PrPSC formation. These studies have all revealed that the degree of homology between secondary structures in the middle third PrPC molecule in particular animals' is crucial in destroying the species barrier in prion diseases.
引用
收藏
页码：17 / 21
页数：5
相关论文
共 50 条
  • [11] Molecular interaction of the cellular and pathogenic PrP describes the species barrier in prion diseases
    Luers, Lars
    Bannach, Oliver
    Riesner, Detlev
    Willbold, Dieter
    Birkmann, Eva
    PRION, 2013, 7 : 82 - 83
  • [12] Oral vaccines for transmissible prion diseases for multiple animal species at risk of infection
    Goni, F.
    Elisei, A.
    Yim, L.
    Marta-Ariza, M.
    Mathiason, C.
    Hoover, E.
    Chabalgoity, J. A.
    Wisniewski, T.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 808 - 808
  • [13] The animal and human prion diseases: Public health importance and risk assessment
    Vitale, K
    Sahin, U
    Greenblatt, C
    PERIODICUM BIOLOGORUM, 2001, 103 (03) : 201 - 217
  • [14] Alpha-synuclein-immunoreactive deposits in human and animal prion diseases
    Haïk S.
    Privat N.
    Adjou K.T.
    Sazdovitch V.
    Dormont D.
    Duyckaerts C.
    Hauw J.J.
    Acta Neuropathologica, 2002, 103 (5) : 516 - 520
  • [15] Alpha-synuclein-immunoreactive deposits in human and animal prion diseases
    Haïk, S
    Privat, N
    Adjou, KT
    Sazdovitch, V
    Dormont, D
    Duyckaerts, C
    Hauw, JJ
    ACTA NEUROPATHOLOGICA, 2002, 103 (05) : 516 - 520
  • [16] Isolation of infectious, oligomeric prions from human and animal prion diseases
    Vanni, I.
    Rathod, V.
    Pirisinu, L.
    Marcon, S.
    Esposito, E.
    Di Bari, M. A.
    Riccardi, G.
    D'Agostino, C.
    Giovannelli, M.
    Erana, H.
    Igel, A.
    Agrimi, U.
    Beringue, V.
    Castilla, J.
    Requena, J.
    Rezaei, H.
    Wille, H.
    Nonno, R.
    PRION, 2024, 18 : 38 - 38
  • [17] Cyclooxygenases and prostaglandin E2 in animal and human prion diseases
    Minghetti, L
    Sbriccoli, M
    Geloso, MC
    Ingrosso, L
    Di Bari, MA
    Greco, A
    Cardone, F
    Pocchiari, M
    PROCEEDINGS OF THE VII EUROPEAN MEETING ON GLIAL CELL FUNCTION IN HEALTH AND DISEASE, 2005, : 25 - 30
  • [18] The prion hypothesis and the human prion diseases
    Aguzzi, AA
    BERLINER UND MUNCHENER TIERARZTLICHE WOCHENSCHRIFT, 2002, 115 (3-4): : 91 - 98
  • [19] Visual pathology in animal prion diseases
    Ye, Xuemin
    HISTOLOGY AND HISTOPATHOLOGY, 2009, 24 (12) : 1563 - 1577
  • [20] HUMAN PRION DISEASES
    PRUSINER, SB
    HSIAO, KK
    ANNALS OF NEUROLOGY, 1994, 35 (04) : 385 - 395
12345